• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

第8章——用于体内精准药物和基因递送的生物纳米胶囊-脂质体缀合物

Chapter 8 - Bio-nanocapsule-liposome conjugates for in vivo pinpoint drug and gene delivery.

作者信息

Kasuya Takeshi, Jung Joohee, Kinoshita Rie, Goh Yasumasa, Matsuzaki Takashi, Iijima Masumi, Yoshimoto Nobuo, Tanizawa Katsuyuki, Kuroda Shun'ichi

机构信息

Institute of Scientific and Industrial Research, Osaka University, Ibaraki, Osaka, Japan.

出版信息

Methods Enzymol. 2009;464:147-66. doi: 10.1016/S0076-6879(09)64008-8.

DOI:10.1016/S0076-6879(09)64008-8
PMID:19903554
Abstract

A bio-nanocapsule (BNC) is an ~50-nm hepatitis B virus (HBV) subviral particle comprising HBV envelope L proteins and a lipid bilayer, and is synthesized in recombinant Saccharomyces cerevisiae. When BNCs are administered intravenously in a mouse xenograft model, they can accumulate specifically in human liver-derived tissues and enter cells efficiently by the HBV-derived human liver-specific infection machinery, localized at the outer-membrane pre-S region of the L protein. BNC specificity for the human liver can be altered to other tissues by substituting the pre-S region using targeting molecules (e.g., antibodies, lectins, cytokines). BNCs can spontaneously form complexes with liposomes (LPs) by the membrane fusogenic activity of the pre-S region. LPs containing various therapeutic materials (e.g., chemicals, proteins, DNA, RNA) can therefore be covered with BNCs to form an ~150-nm BNC-LP conjugate. BNC-LP conjugates injected intravenously can deliver incorporated materials to target tissues specifically and efficiently by utilizing the HBV-derived infection machinery. The stability of BNC-LP conjugates in the blood circulation is similar to that of PEGylated LPs. In this chapter, we describe the preparation and in vivo application of BNC-LP conjugates, and the potential of BNC-LP conjugates as in vivo pinpoint drug delivery systems.

摘要

生物纳米胶囊(BNC)是一种约50纳米的乙型肝炎病毒(HBV)亚病毒颗粒,由HBV包膜L蛋白和脂质双层组成,在重组酿酒酵母中合成。当在小鼠异种移植模型中静脉注射BNC时,它们可以特异性地积聚在人肝衍生组织中,并通过位于L蛋白外膜前S区域的HBV衍生的人肝特异性感染机制有效地进入细胞。通过使用靶向分子(例如抗体、凝集素、细胞因子)替代前S区域,可以将BNC对人肝脏的特异性改变为对其他组织的特异性。BNC可以通过前S区域的膜融合活性与脂质体(LP)自发形成复合物。因此,含有各种治疗物质(例如化学物质、蛋白质、DNA、RNA)的LP可以被BNC覆盖,形成约150纳米的BNC-LP缀合物。静脉注射的BNC-LP缀合物可以通过利用HBV衍生的感染机制将掺入的物质特异性且高效地递送至靶组织。BNC-LP缀合物在血液循环中的稳定性与聚乙二醇化LP的稳定性相似。在本章中,我们描述了BNC-LP缀合物的制备及其体内应用,以及BNC-LP缀合物作为体内精准给药系统的潜力。

相似文献

1
Chapter 8 - Bio-nanocapsule-liposome conjugates for in vivo pinpoint drug and gene delivery.第8章——用于体内精准药物和基因递送的生物纳米胶囊-脂质体缀合物
Methods Enzymol. 2009;464:147-66. doi: 10.1016/S0076-6879(09)64008-8.
2
Bio-nanocapsule conjugated with liposomes for in vivo pinpoint delivery of various materials.与脂质体结合的生物纳米胶囊用于体内各种物质的精准递送。
J Control Release. 2008 Mar 20;126(3):255-64. doi: 10.1016/j.jconrel.2007.12.002. Epub 2007 Dec 14.
3
Intracellular trafficking of bio-nanocapsule-liposome complex: Identification of fusogenic activity in the pre-S1 region of hepatitis B virus surface antigen L protein.生物纳米胶囊脂质体复合物的细胞内运输:乙型肝炎病毒表面抗原 L 蛋白前 S1 区融合活性的鉴定。
J Control Release. 2015 Aug 28;212:10-8. doi: 10.1016/j.jconrel.2015.06.012. Epub 2015 Jun 12.
4
Efficient and rapid purification of drug- and gene-carrying bio-nanocapsules, hepatitis B virus surface antigen L particles, from Saccharomyces cerevisiae.从酿酒酵母中高效快速纯化携带药物和基因的生物纳米胶囊——乙型肝炎病毒表面抗原L颗粒。
Protein Expr Purif. 2011 Aug;78(2):149-55. doi: 10.1016/j.pep.2011.04.008. Epub 2011 Apr 14.
5
Hepatitis B virus envelope L protein-derived bio-nanocapsules: mechanisms of cellular attachment and entry into human hepatic cells.乙型肝炎病毒包膜 L 蛋白衍生的生物纳米胶囊:进入人肝细胞的细胞附着和进入机制。
J Control Release. 2012 Jun 10;160(2):322-9. doi: 10.1016/j.jconrel.2011.11.004. Epub 2011 Nov 10.
6
Expression of squamous cell carcinoma antigen-1 in liver enhances the uptake of hepatitis B virus envelope-derived bio-nanocapsules in transgenic rats.鳞状细胞癌抗原-1在肝脏中的表达增强了转基因大鼠对乙肝病毒包膜衍生生物纳米胶囊的摄取。
FEBS J. 2008 Nov;275(22):5714-24. doi: 10.1111/j.1742-4658.2008.06698.x.
7
Bio-nanocapsules displaying various immunoglobulins as an active targeting-based drug delivery system.展示各种免疫球蛋白的生物纳米胶囊作为一种基于主动靶向的药物递送系统。
Acta Biomater. 2016 Apr 15;35:238-47. doi: 10.1016/j.actbio.2016.02.010. Epub 2016 Feb 10.
8
Development of a macrophage-targeting and phagocytosis-inducing bio-nanocapsule-based nanocarrier for drug delivery.基于巨噬细胞靶向和吞噬诱导的生物纳米胶囊的药物递送纳米载体的研制。
Acta Biomater. 2018 Jun;73:412-423. doi: 10.1016/j.actbio.2018.04.023. Epub 2018 Apr 16.
9
Electroporation and use of hepatitis B virus envelope L proteins as bionanocapsules.电穿孔法以及将乙肝病毒包膜L蛋白用作生物纳米胶囊
Cold Spring Harb Protoc. 2012 Jun 1;2012(6):702-5. doi: 10.1101/pdb.prot069534.
10
Complex carriers of affibody-displaying bio-nanocapsules and composition-varied liposomes for HER2-expressing breast cancer cell-specific protein delivery.展示亲和体的生物纳米胶囊的复杂载体和组成变化的脂质体,用于 HER2 表达的乳腺癌细胞特异性蛋白递药。
J Drug Target. 2012 Dec;20(10):897-905. doi: 10.3109/1061186X.2012.725404. Epub 2012 Oct 1.

引用本文的文献

1
Polymerized Albumin Receptor of Hepatitis B Virus for Evading the Reticuloendothelial System.乙型肝炎病毒用于逃避网状内皮系统的聚合白蛋白受体
Pharmaceuticals (Basel). 2021 Apr 25;14(5):408. doi: 10.3390/ph14050408.
2
Current Progress of Virus-mimicking Nanocarriers for Drug Delivery.用于药物递送的病毒模拟纳米载体的当前进展
Nanotheranostics. 2017 Oct 31;1(4):415-429. doi: 10.7150/ntno.21723. eCollection 2017.
3
Elucidation of the early infection machinery of hepatitis B virus by using bio-nanocapsule.利用生物纳米胶囊阐明乙型肝炎病毒的早期感染机制。
World J Gastroenterol. 2016 Oct 14;22(38):8489-8496. doi: 10.3748/wjg.v22.i38.8489.
4
Structural Characterization of the Avidin Interactions with Fluorescent Pyrene-Conjugates: 1-Biotinylpyrene and 1-Desthiobiotinylpyrene.抗生物素蛋白与荧光芘共轭物(1-生物素基芘和1-脱硫生物素基芘)相互作用的结构表征
Molecules. 2016 Sep 27;21(10):1270. doi: 10.3390/molecules21101270.
5
Virosomes of hepatitis B virus envelope L proteins containing doxorubicin: synergistic enhancement of human liver-specific antitumor growth activity by radiotherapy.含有阿霉素的乙型肝炎病毒包膜L蛋白病毒体:放疗对人肝脏特异性抗肿瘤生长活性的协同增强作用
Int J Nanomedicine. 2015 Jun 25;10:4159-72. doi: 10.2147/IJN.S84295. eCollection 2015.
6
Targeting cancer cell-specific RNA interference by siRNA delivery using a complex carrier of affibody-displaying bio-nanocapsules and liposomes.利用展示亲和体的生物纳米胶囊和脂质体复合物载体进行 siRNA 递送来靶向癌细胞特异性的 RNA 干扰。
J Nanobiotechnology. 2013 Jun 24;11:19. doi: 10.1186/1477-3155-11-19.
7
Nanopod formation through gold nanoparticle templated and catalyzed cross-linking of polymers bearing pendant propargyl ethers.通过金纳米粒子模板化和催化带有侧基炔丙基醚的聚合物的交联形成纳米荚。
J Am Chem Soc. 2010 Nov 3;132(43):15151-3. doi: 10.1021/ja107224s.